Collectively the founders of Integrated Diagnostics have 20 issued patents, over 990 publications and have started 20 biotech companies, two of which (Amgen and Applied Biosystems) have combined market capitalization over $50B.
Lee Hood
Founder and Board Member
An unparalleled pioneer in the translation of technology from R&D to industry, Dr. Hood has co-founded more than 14 biotechnology companies, including Amgen, Applied Biosystems, Systemix, Darwin and Rosetta. Amgen and Applied Biosystems have a combined market capitalization of over $50B. He is a member of the National Academy of Sciences, the American Philosophical Society, the American Academy of Arts and Sciences, the Institute of Medicine and the National Academy of Engineering. Indeed, he is one of only 7 members out of more than 6000 that are in all three US National Academies (NAS, IOM, and NAE). Dr. Hood is the recipient of numerous awards including the Lasker Award, Kyoto Prize, Lemelson-MIT Prize for Invention and Innovation among many others. Dr. Hood has over 600 publications, 15 patents and written multiple textbooks in diverse areas.
David Galas
Founder and Scientific Advisor
Dr. Galas is Senior Vice President of strategic partnerships at ISB. He was previously Chancellor, CSO and Norris Professor of Applied Life Science at the Keck Graduate Institute of Applied Life Sciences (KGI), in Claremont CA. Prior to founding KGI, Dr. Galas served as President and CSO of Chiroscience R&D Inc. following the acquisition of Darwin Molecular Corporation, which Dr. Galas co-founded in 1993. Prior to his involvement in the biotechnology industry, Dr. Galas served as Director for Health and Environmental Research at the U.S. Department of Energy's Office of Science, where he headed the DOE's Human Genome Project from 1990 to 1993, on leave from the University of Southern California, where he was Professor of Molecular Biology for twelve years, and directed the Molecular Biology section of the Biological Science Department. Dr. Galas has been active in several areas of science and technology related to medicine holds several patents in these fields. He has severed on several corporate boards and science advisory boards. He was recipient of the Smithsonian-Computerworld Pioneer Award in 2001. He was a Fannie and John Hertz Foundation predoctoral fellow and is a Lifetime Associate of the National Academy of Sciences.
Jim Heath
Founder and Board Member
Dr. Heath is Gilloon Professor and Professor of Chemistry at the California Institute of Technology. He received a B.Sc. degree in chemistry from Baylor University in 1984, and a Ph.D. degree in chemistry from Rice University in 1988, where he studied in the group of Richard E. Smalley. Dr. Heath was a Miller Postdoctoral Fellow at UC Berkeley from 1988 to 1991, and a research staff member at the IBM T.J. Watson Research Labs in Yorktown Heights, New York from 1991 to 1994. In 1994 he left IBM to join the Department of Chemistry and Biochemistry at UCLA. He was the founding director of the California NanoSystems Institute (CNSI), prior to moving to Caltech in 2003. Heath is a Fellow of the American Physical Society, and his awards include Jules Springer Award in Applied Physics (2000); the Feynman Prize (2000); the Sackler Prize in the Physical Sciences (2001), and the Spiers Medal from the Royal Society (2005). Dr. Heath directs the National Cancer Institute-funded NanoSystems Biology Cancer Center, and has been a founder of a number of startup companies, including MTI (acquired by Siemens in 2005), NanoSys, Inc., and Momentum Biosciences, which is a biotech incubator currently operating in Los Angeles.
Paul Kearney
Founder, President & CSO
In 2008 Paul Kearney joined the Institute for Systems Biology as Scientific Director of Special Projects where he helped establish a $100M collaboration in Personalized Medicine between ISB and the University of Luxembourg. Previously, Dr. Kearney was VP Bioinformatics at Caprion Proteomics, a leading provider of proteomics services for biomarker discovery. At Caprion he managed technology R&D, oversaw all aspects of data analysis, IT and biomarker panel discovery and experimental design. Prior to Caprion, Dr. Kearney was co-founder and VP R&D of Bioinformatics Solutions (BSI), a provider of genomic and proteomic data analysis tools. BSI won an R&D 100 award and the CASP4 competition for its PROSPECT tool for automated protein structure prediction. Prior to BSI, Dr. Kearney was assistant professor of Computer Science at the University of Waterloo where he was the founder and inaugural Director of the Bioinformatics Program.